相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study
Ayman Tourbah et al.
CNS DRUGS (2018)
Application of CRISPR-Cas9 Based Genome-Wide Screening Approaches to Study Cellular Signalling Mechanisms
Sumana Sharma et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Progress in understanding the pathophysiology of multiple sclerosis
H. Zephir
REVUE NEUROLOGIQUE (2018)
Multiple Sclerosis Pathology
Hans Lassmann
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
Biotin: From Nutrition to Therapeutics
Donald M. Mock
JOURNAL OF NUTRITION (2017)
Modeling human disease in rodents by CRISPR/Cas9 genome editing
Marie-Christine Birling et al.
MAMMALIAN GENOME (2017)
Neuroprotective potential of high-dose biotin
Mark F. McCarty et al.
MEDICAL HYPOTHESES (2017)
A treatable cause of myelopathy and vision loss mimicking neuromyelitis optica spectrum disorder: late-onset biotinidase deficiency
Sanem Yilmaz et al.
METABOLIC BRAIN DISEASE (2017)
High dose biotin as treatment for progressive multiple sclerosis
Gary Birnbaum et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2017)
MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study
Ayman Tourbah et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Targeting demyelination and virtual hypoxia with high-dose biotin as a treatment for progressive multiple sclerosis
Frederic Sedel et al.
NEUROPHARMACOLOGY (2016)
Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis
Afsaneh Shirani et al.
NEUROTHERAPEUTICS (2016)
MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study
Ayman Tourbah et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Genetic screens and functional genomics using CRISPR/Cas9 technology
Ella Hartenian et al.
FEBS JOURNAL (2015)
High doses of biotin in chronic progressive multiple sclerosis: A pilot study
Frederic Sedel et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2015)
Biotin-Responsive Basal Ganglia Disease: Neuroimaging Features before and after Treatment
H. Kassem et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2014)
A Systematic Review of Randomized, Double-Blind, Placebo-Controlled Trials Examining the Clinical Efficacy of Vitamin D in Multiple Sclerosis
Beatriz Pozuelo-Moyano et al.
NEUROEPIDEMIOLOGY (2013)
Biotin-responsive basal ganglia disease should be renamed biotin-thiamine-responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of 18 new cases
Majid Alfadhel et al.
ORPHANET JOURNAL OF RARE DISEASES (2013)
Vitamin D and multiple sclerosis: epidemiology, immunology, and genetics
Kelly C. Simon et al.
CURRENT OPINION IN NEUROLOGY (2012)
Biotinidase deficiency: if you have to have an inherited metabolic disease, this is the one to have
Barry Wolf
GENETICS IN MEDICINE (2012)
An unanticipated architecture of the 750-kDa α6β6 holoenzyme of 3-methylcrotonyl-CoA carboxylase
Christine S. Huang et al.
NATURE (2012)
Analysis of Mutations Causing Biotinidase Deficiency
Kirit Pindolia et al.
HUMAN MUTATION (2010)
ACC2 Is Expressed at High Levels Human White Adipose and Has an Isoform with a Novel N-Terminus
John C. Castle et al.
PLOS ONE (2009)
Metabolic and Structural Role of Thiamine in Nervous Tissues
Abdoulaye Ba
CELLULAR AND MOLECULAR NEUROBIOLOGY (2008)
Impaired Biotinidase Activity Disrupts Holocarboxylase Synthetase Expression in Late Onset Multiple Carboxylase Deficiency
Anylu Perez-Monjaras et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Biotin-responsive basal ganglia disease-linked mutations inhibit thiamine transport via hTHTR2: biotin is not a substrate for hTHTR2
Veedamali S. Subramanian et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
Mutations in the holocarboxylase synthetase gene HLCS
Y Suzuki et al.
HUMAN MUTATION (2005)
Biotin availability regulates expression of the sodium-dependent multivitamin transporter and the rate of biotin uptake in HepG2 cells
D Pacheco-Alvarez et al.
MOLECULAR GENETICS AND METABOLISM (2005)
Biotin-responsive basal ganglia disease maps to 2q36.3 and is due to mutations in SLC19A3
WQ Zeng et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
Biotin deficiency reduces expression of SLC19A3, a potential biotin transporter, in leukocytes from human blood
TI Vlasova et al.
JOURNAL OF NUTRITION (2005)
Paradoxical regulation of biotin utilization in brain and liver and implications for inherited multiple carboxylase deficiency
D Pacheco-Alvarez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Localization of biotinidase in the brain: implications for its role in hearing loss in biotinidase deficiency
AJ Heller et al.
HEARING RESEARCH (2002)
Holocarboxylase synthetase is an obligate participant in biotin-mediated regulation of its own expression and of biotin-dependent carboxylases mRNA levels in human cells
RS Solórzano-Vargas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Expression in Escherichia coli of N- and C-terminally deleted human holocarboxylase synthetase -: Influence of the N-terminus on biotinyilation and identification of a minimum functional protein
E Campeau et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Carboxylation and anaplerosis in neurons and glia
B Hassel
MOLECULAR NEUROBIOLOGY (2000)
Biotin and biocytin uptake into cultured primary calf brain microvessel endothelial cells of the blood-brain barrier
B Baur et al.
BRAIN RESEARCH (2000)
The subcellular localization of acetyl-CoA carboxylase 2
L Abu-Elheiga et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
